Prevalence of Obesity and Metabolic Syndrome in Taiwan

Obesity and metabolic syndrome (MS) are major risk factors for the development of type 2 diabetes and cardiovascular diseases (CVD). This study estimated the prevalence of obesity and MS in Taiwan. Methods: Data from a nationwide cross-sectional population-based survey of 5936 participants (2815 men...

Full description

Bibliographic Details
Main Author: Lee-Ching Hwang
Format: Article
Language:English
Published: Elsevier 2006-01-01
Series:Journal of the Formosan Medical Association
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664609601613
id doaj-2fd674266a7344b29815fc81abf768f2
record_format Article
spelling doaj-2fd674266a7344b29815fc81abf768f22020-11-24T23:24:35ZengElsevierJournal of the Formosan Medical Association0929-66462006-01-01105862663510.1016/S0929-6646(09)60161-3Prevalence of Obesity and Metabolic Syndrome in TaiwanLee-Ching HwangObesity and metabolic syndrome (MS) are major risk factors for the development of type 2 diabetes and cardiovascular diseases (CVD). This study estimated the prevalence of obesity and MS in Taiwan. Methods: Data from a nationwide cross-sectional population-based survey of 5936 participants (2815 men, 3121 women; age range, 20-79.9 years) in 2002 were analyzed. Obesity was defined as a body mass index (BMI) ≥ 27 kg/m2 according to the criteria of the Department of Health in Taiwan. The prevalence of MS was estimated using the definitions of the modified Adult Treatment Panel III (ATP III), the International Diabetes Federation for Chinese (MS-IDF(C)) and the MS criteria for Taiwanese (MS-TW). Results: The overall prevalence of obesity in men was significantly greater than in women (19.2% vs. 13.4%, p < 0.0001). The age-standardized prevalence of MS was 15.7% by the modified ATP III criteria, 14.3% by the MS-IDF(C) criteria and 16.4% by the MS-TW criteria. The prevalence of obesity and MS significantly increased with age (trend test, p<0.0001) in men and women. The risk of MS and its components increased significantly with BMI, and showed a marked increase with BMI ≥ 24 kg/m2. MS as classified by the MS-IDF(C) criteria failed to identify subjects at high risk of CVD who did not have abdominal obesity, including those with hypertension, type 2 diabetes and dyslipidemia. Conclusion: This study found a high prevalence of obesity and MS in Taiwan. The definitions of MS by the modified ATP III and MS-TW criteria were better able to detect high CVD risk than the MS-IDF(C) criteria.http://www.sciencedirect.com/science/article/pii/S0929664609601613body mass indexmetabolic syndromeobesityprevalence
collection DOAJ
language English
format Article
sources DOAJ
author Lee-Ching Hwang
spellingShingle Lee-Ching Hwang
Prevalence of Obesity and Metabolic Syndrome in Taiwan
Journal of the Formosan Medical Association
body mass index
metabolic syndrome
obesity
prevalence
author_facet Lee-Ching Hwang
author_sort Lee-Ching Hwang
title Prevalence of Obesity and Metabolic Syndrome in Taiwan
title_short Prevalence of Obesity and Metabolic Syndrome in Taiwan
title_full Prevalence of Obesity and Metabolic Syndrome in Taiwan
title_fullStr Prevalence of Obesity and Metabolic Syndrome in Taiwan
title_full_unstemmed Prevalence of Obesity and Metabolic Syndrome in Taiwan
title_sort prevalence of obesity and metabolic syndrome in taiwan
publisher Elsevier
series Journal of the Formosan Medical Association
issn 0929-6646
publishDate 2006-01-01
description Obesity and metabolic syndrome (MS) are major risk factors for the development of type 2 diabetes and cardiovascular diseases (CVD). This study estimated the prevalence of obesity and MS in Taiwan. Methods: Data from a nationwide cross-sectional population-based survey of 5936 participants (2815 men, 3121 women; age range, 20-79.9 years) in 2002 were analyzed. Obesity was defined as a body mass index (BMI) ≥ 27 kg/m2 according to the criteria of the Department of Health in Taiwan. The prevalence of MS was estimated using the definitions of the modified Adult Treatment Panel III (ATP III), the International Diabetes Federation for Chinese (MS-IDF(C)) and the MS criteria for Taiwanese (MS-TW). Results: The overall prevalence of obesity in men was significantly greater than in women (19.2% vs. 13.4%, p < 0.0001). The age-standardized prevalence of MS was 15.7% by the modified ATP III criteria, 14.3% by the MS-IDF(C) criteria and 16.4% by the MS-TW criteria. The prevalence of obesity and MS significantly increased with age (trend test, p<0.0001) in men and women. The risk of MS and its components increased significantly with BMI, and showed a marked increase with BMI ≥ 24 kg/m2. MS as classified by the MS-IDF(C) criteria failed to identify subjects at high risk of CVD who did not have abdominal obesity, including those with hypertension, type 2 diabetes and dyslipidemia. Conclusion: This study found a high prevalence of obesity and MS in Taiwan. The definitions of MS by the modified ATP III and MS-TW criteria were better able to detect high CVD risk than the MS-IDF(C) criteria.
topic body mass index
metabolic syndrome
obesity
prevalence
url http://www.sciencedirect.com/science/article/pii/S0929664609601613
work_keys_str_mv AT leechinghwang prevalenceofobesityandmetabolicsyndromeintaiwan
_version_ 1725559994362888192